First Allied Advisory Services’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding GHDX
BBA
First Allied Advisory Services's GHDX Position: Q3 2018 in Review
First Allied Advisory Services sold out of Genomic Health, Inc. (GHDX) in Q3 2018, closing a stake of 6,827 shares — an estimated $345K sold.
First Allied Advisory Services first reported a position in GHDX in Q2 2018 and held it in 1 quarter. The position peaked at $345K in Q2 2018. 201 funds tracked by Wall St. Rank hold GHDX as of Q3 2018.
- First Allied Advisory Services reported no remaining Genomic Health, Inc. position as of Q3 2018 after selling out during the quarter.
- First Allied Advisory Services sold 6,827 Genomic Health, Inc. shares in Q3 2018, an estimated $345K.
- First Allied Advisory Services first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 1 quarter.
- First Allied Advisory Services's Genomic Health, Inc. position peaked at $345K in Q2 2018.
- 201 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2018.
Based on First Allied Advisory Services's 13F filing for Q3 2018, filed 14 Nov 2018.